Candel Therapeutics, Inc. (CADL) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$48.27M | -44.6% |
| 2024 | -$33.37M | +13.1% |
| 2023 | -$38.39M | -10.6% |
| 2022 | -$34.72M | -35.0% |
| 2021 | -$25.73M | -86.3% |
| 2020 | -$13.81M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$48.27M | -44.6% |
| 2024 | -$33.37M | +13.1% |
| 2023 | -$38.39M | -10.6% |
| 2022 | -$34.72M | -35.0% |
| 2021 | -$25.73M | -86.3% |
| 2020 | -$13.81M | — |